Boileau, C., Martel-Pelletier, J., Brunet, J., Tardif, G., Schrier, D., Flory, C., . . . Pelletier, J. (2004). Oral treatment with PD-0200347, an α(2)δ ligand, reduces the development of experimental osteoarthritis by inhibiting the chondrocytes metalloproteases and inducible nitric oxide synthase gene expression and synthesis. BioMed Central.
শিকাগো স্টাইলে সাইটেশনBoileau, C., J. Martel-Pelletier, J. Brunet, G. Tardif, D. Schrier, C. Flory, M. Boily, এবং J-P Pelletier. Oral Treatment With PD-0200347, an α(2)δ Ligand, Reduces the Development of Experimental Osteoarthritis By Inhibiting the Chondrocytes Metalloproteases and Inducible Nitric Oxide Synthase Gene Expression and Synthesis. BioMed Central, 2004.
এমএলএ সাইটেশনBoileau, C., et al. Oral Treatment With PD-0200347, an α(2)δ Ligand, Reduces the Development of Experimental Osteoarthritis By Inhibiting the Chondrocytes Metalloproteases and Inducible Nitric Oxide Synthase Gene Expression and Synthesis. BioMed Central, 2004.